Wafra Inc’s ResMed RMD Stock Holding History

Wafra Inc’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-17,550	Closed	-$826K	–	76
2013 Q4	$826K	Hold	17,550	–	–	0.11%	72
2013 Q3	$927K	Hold	17,550	–	–	0.13%	64
2013 Q2	$792K	Buy	+17,550	New	+$833K	0.13%	62

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Wafra Inc's RMD Position: Q1 2014 in Review

Wafra Inc sold out of ResMed (RMD) in Q1 2014, closing a stake of 17,550 shares — an estimated $826K sold.

Wafra Inc first reported a position in RMD in Q2 2013 and held it in 3 quarters. The position peaked at $927K in Q3 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

Wafra Inc reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
Wafra Inc sold 17,550 ResMed shares in Q1 2014, an estimated $826K.
Wafra Inc first reported a position in ResMed in Q2 2013 and held it in 3 quarters.
Wafra Inc's ResMed position peaked at $927K in Q3 2013.
318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Wafra Inc's 13F filing for Q1 2014, filed 12 May 2014.